Organon’s VTAMA achieved up to 70% EASI75 response in one eczema subgroup. How broadly do the results apply?
Organon reports VTAMA responses across atopic dermatitis subgroups. See what Phase 3 data reveal about EASI75, itch and treatment limitations.
